Overview:
We offers PCR-based confirmatory testing options from Yourgene Health. This solution uses Quantitative Fluorescence-Polymerase Chain Reaction (QF-PCR) for rapid in vitro quantitative analysis of autosomal and sex chromosome aneuploidies. The results are obtained from amniocentesis and/or Chorionic Villus Sampling (CVS) and are used to confirm high-risk screening outcomes from NIPT (Non-Invasive Prenatal Testing) investigations. Using PCR amplification, fluorescent dye labelled primers target highly polymorphic regions of DNA sequence, short tandem repeats (STRs), located on the chromosomes of interest.
Features:
CE-IVD marked
- High quality, fully validated and regulated product requires minimal validation to fit into your workflow
Rapid Workflow
- Fast workflow enables rapid delivery of results, enabling laboratories to maintain best service TAT
- Patients receive results quickly, permitting timely downstream management
Single Tube Assay
- Simple to use; just add DNA
- Fewer reagents to improve economies of testing
Reliable Performance
- Optically balanced primers to maximise ease-of-interpretation and reduce analysis burden
Compatible with ABI 3130/3500/SeqStudio Genetic Analyser Platform
- Developed for maximum compatibility with existing workflow
Aligned to clinical guidelines and pathways
- Meaningful results for appropriate clinical management
